ALMKT:EPA
Mauna Kea Technologies SA
0,14 €
0,00%
(0,00) 1D
1 қаз., 17:35:10 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
0,14 €
High
0,14 €
Low
0,13 €
Mkt. cap
27,34 млн
Avg. vol.
416,28 м.
Volume
308,80 м.
P/E ratio
1,15
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 млн
No. of employees
59
Open
0,14 €
High
0,14 €
Low
0,13 €
Mkt. cap
27,34 млн
Avg. vol.
416,28 м.
Volume
308,80 м.
P/E ratio
1,15
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 млн
No. of employees
59
News stories
From web sources and news partners
Kalkine Media
·
23 минут бұрын
What Does Federal Rescheduling Delay Mean for Trulieve (NYSE:TRUL)?
PR Web
·
52 минут бұрын
Youth INC to Honor Nasdaq's Bob McCooey with the John C. Whitehead Leadership Award
巴士的報
·
47 минут бұрын
Kroger Launches Mastercard Powered by Payments Platform Imprint: NYSE Content Update
24/7 Wall St.
·
41 минут бұрын
If The S&P 500 Doesn’t Hit 10,000, This ETF Is Going To Zero
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA